Frequently Asked Questions

What is the purpose of the Sanofi CHC open innovation portal?

The Sanofi Consumer Healthcare open innovation team launched the portal in order to have a single location to collect and assess ideas and innovations for innovative medical technologies, disruptive technology in healthcare and other solutions to develop partnerships in healthcare.

Who can/should submit to the Sanofi open innovation portal?

Sanofi is interested in receiving ideas and innovations from partners in healthcare including individuals, startups, research institutions, and more. Anyone over 18 years of age can submit to the portal.

Why should people submit to the Sanofi open innovation portal?

Innovative healthcare solution providers can benefit from Sanofi's research and scientific capabilities, consumer insight and marketing expertise, world-class global distribution for healthcare solutions, and expertise in legal, medical, and regulatory knowledge.

What is Sanofi currently looking for through its health innovation portal and idea submission platform?

Sanofi is seeking disruptive healthcare innovations in the areas of:

  • Digestive health
  • Cough and cold, allergy
  • Pain
  • Nutritional health

Visit our current needs to view Sanofi's specific searches for disruptive healthcare solutions or new innovative consumer products. Note that Sanofi accepts innovations and ideas submissions beyond the currently posted needs.

What types of solutions is Sanofi looking for in the category of digestion?

Sanofi is looking for disruptive healthcare solutions in digestive health. We are looking for solutions that address constipation relief, liver health, and more. Visit our current needs in digestive health to view our specific searches for disruptive healthcare solutions or new innovative consumer products.

What innovations is Sanofi looking for in the cough and cold and allergy category?

The Sanofi open innovation portal is actively seeking disruptive health solutions for user-friendly packaging, innovative packaging, smart and passive solutions to track symptoms in allergy, machine learning algorithm for allergy management, boosting features for nasal sprays, innovative cough capsule formulations, and more. Visit our current needs in cough and cold, allergy for more details.

What types of solutions is Sanofi looking for in the pain category?

Sanofi is seeking disruptive healthcare solutions in pain for intense headaches, lower abdominal pain, IBS symptoms, PM relief for body pain, and more. View our current needs in pain to see Sanofi's specific searches for disruptive healthcare solutions or new innovative consumer products.

What is Sanofi looking for in nutritional health?

Sanofi is seeking innovations in nutritional health for prebiotics, probiotics, non-invasive diagnostic tools for analysis of biomarkers, adaptogens, and more. Learn more about Sanofi's searches by visiting our current needs for nutritional health innovations.

What happens after I submit?

When you submit your idea through Sanofi's corporate Open Innovation Portal for disruptive healthcare solutions, you will be asked to complete a "Submission Form" that includes your contact details, a non-confidential overview of your healthcare innovation or solution and your agreement to the Terms and Conditions of submission and the Privacy Notice. On behalf of Sanofi, yet2 will review your details and evaluate the solution within the portal.

Why yet2?

yet2 has significant experience in how companies acquire and divest technology and understand the best approaches to reviewing technology and identifying its fit to the needs of an organization whilst ensuring adequate protection for each party. Furthermore, yet2 understands the nuances between large companies and smaller technology innovators and successfully manage thousands of introductions for successful partnerships each day.

Who decides if my submission is of interest to Sanofi?

yet2 will review your innovation idea submission form in relation to criteria provided by Sanofi's Open Innovation team. yet2 will follow up directly with you through the Sanofi Open Innovation portal to inform you of the status of your submission.

How long will it take for my submission to be reviewed? What are the stages?

The status of your submission to Sanofi's open innovation portal for disruptive healthcare solutions will be communicated within four weeks of receipt.

Step 1: You will receive a confirmation of receipt of your submission form via email with your personal submission identification number from yet2.

Step 2: An initial review will be conducted by yet2, on behalf of Sanofi, within approximately five working days. Once the review is completed you will be informed of your submission status via email.

Step 3: If yet2's initial review is positive, your submission will be further reviewed by the Sanofi Consumer Healthcare (CHC) Open Innovation team. You will be informed of the status within four weeks.

Step 4: If the further review is positive, the Sanofi CHC Open Innovation team will contact you directly to discuss next steps for a potential collaboration. Additional information may be requested at this stage.

Step 5: Once all information has been reviewed and there is mutual consent to move forward, you and the Sanofi Open Innovation team will begin to collaborate.

What information does my submission need to include?

Contact information is essential to follow up. The submission form must also provide an overview of the proposed solution for healthcare, with the understanding that your submission will be treated as non-confidential.

Can I submit confidential information?

You can only submit Non-Confidential information. Throughout the submission process, we ask for only information that imposes no obligations of confidentiality for Sanofi or yet2 and does not breach any confidentiality obligations that you as the submitter owe to others. If confidential information is later required, we may negotiate a separate Confidential Disclosure Agreement or NDA prior to sharing or receiving any confidential information.

Is there a reward for submitting my innovation?

No. There will be no reward for your initial submission of an idea through this portal. However, if Sanofi decides to pursue your submission for disruptive healthcare solutions or new innovative consumer products, a mutually-agreed contract and appropriate commercial terms will be negotiated on a case-by-case basis.

Do I have to accept the Submission Portal Terms & Conditions?

Yes, these are created to protect you and your rights, as well as eliminating the risk of jeopardizing Sanofi ongoing research programs, projects and developing concepts.

If I have more than one submission, will I have to agree to a waiver for each submission?

Yes, you will have to agree to the Terms and Conditions for each submission

Do I have to have Intellectual Property protection? (Patents applied for or filed)

Ideally, your solution will be protected by granted or applied-for patents.

However, Sanofi is willing to discuss early stage ideas before a patent filing has been made or before it has been published. If you have not filed for patents yet, you should absolutely avoid disclosing any information that jeopardizes your rights to file patents. We advise you contact an IP lawyer prior to submission.

Do I have to be at least 18 years old to submit an innovation?

Yes, this is the legally-accepted age for agreeing to terms and conditions for this activity.

I cannot log into the My Submissions page to view the status of my submission, upload additional documentation or respond to communication. What do I do?

Please ensure that you are only using the eight character alphanumeric reference number to login. Do not include the # preceding it. Please also ensure that you are entering O (capital "o") and 0 (zero) correctly. If that fails, please contact sanofiportal@yet2.com

Why have I been redirected from Sanofi.com to a separate portal to submit my innovation?

Sanofi wants to ensure that all submitter responses are reviewed in a timely manner.

Sanofi understands that solutions can be provided by a variety of sources: some that may require support in describing the solution in a way that enables more clarity on how it solves a need. yet2 has significant experience in this area and is able to facilitate the process for ensuring best chance of success.

Ensuring only Non-Confidential information is received eliminates the risk of jeopardizing your rights as well as those of Sanofi. Sanofi may be developing similar concepts, so sharing only Non-Confidential information is important for protecting Sanofi's IP position as well as your own. yet2 acts as a gatekeeper.